Cost-Effectiveness Analysis Of Triple Therapy With Peginterferon, Ribavirin, And Boceprevir For The Treatment Of Chronic Hepatitis C Virus Genotype 1 With Severe Fibrosis Under "Real-Life" Conditions

Value Health. 2014 Nov;17(7):A367. doi: 10.1016/j.jval.2014.08.822. Epub 2014 Oct 26.
No abstract available